购物车
您的购物车当前为空
Human IgG1 kappa-Deruxtecan, ADC Control (DAR 8) is an IgG1-based antibody-drug conjugate control containing Deruxtecan (DXd) with an average DAR of 8. It can be used as a control in ADC.
Human IgG1 kappa-Deruxtecan, ADC Control (DAR 8) is an IgG1-based antibody-drug conjugate control containing Deruxtecan (DXd) with an average DAR of 8. It can be used as a control in ADC.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 5,300 | 待询 | |
| 5 mg | ¥ 11,900 | 待询 | |
| 10 mg | 待询 | 待询 |
| 产品描述 | Human IgG1 kappa-Deruxtecan, ADC Control (DAR 8) is an IgG1-based antibody-drug conjugate control containing Deruxtecan (DXd) with an average DAR of 8. It can be used as a control in ADC. |
| 反应种属 | Human |
| 应用 | ELISA FCM Functional assay |
| 缓冲液 | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| 内毒素 | <1.0 EU/mg |
| 同型 | Human IgG1 kappa |
| 偶联 | Deruxtecan |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多